galactosamine has been researched along with emodin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Hattori, M; Lin, CC; Namba, T; Yang, JJ | 1 |
| Gong, X; Jiang, R; Kuang, G; Wan, J; Wang, B; Xu, G; Yin, X; Zhang, L | 1 |
2 other study(ies) available for galactosamine and emodin
| Article | Year |
|---|---|
Hepatoprotective effects of emodin from Ventilago leiocarpa.
Topics: Acetates; Analysis of Variance; Animals; Carbon Tetrachloride; Chemical Fractionation; Chloroform; Emodin; Enzyme Inhibitors; Galactosamine; Hyalin; Kupffer Cells; Liver; Lymphocytes; Male; Necrosis; Plant Extracts; Rats; Rats, Wistar | 1996 |
Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Emodin; Extracellular Signal-Regulated MAP Kinases; Galactosamine; Gene Expression Regulation; Humans; Immunization; Lipopolysaccharides; Liver Failure, Acute; Lymphocyte Antigen 96; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |